Dnmt3b gene deficient type CHO (Chinese hamster ovary) cell line, preparation method and application thereof and recombinant protein expression system
A gene defect and expression system technology, applied in the field of genetic engineering, can solve problems such as low expression level, unsatisfactory expression stability of target protein, promoter DNA methylation, etc., to improve expression level, improve expression stability, overcome low expression effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0050] The preparation method of the DNA methyltransferase Dnmt3b gene-deficient CHO cell line in this embodiment includes the following steps:
[0051] 1. Determine the target site for candidate genes
[0052] 1) Amplify the partial sequence of DNA methyltransferase gene Dnmt3b gene:
[0053] According to NCBI GenBank Chinese hamster DNA methyltransferase gene Dnmt3b genome sequence (No. NW_006879210) design amplification primers:
[0054] Dnmt3b-Ex1PCR-L: 5'-GTGCCCCCATTTCTCCTACT-3' (as shown in SEQ ID NO.3);
[0055] Dnmt3b-Ex1PCR-R: 5'-AGACCCAATGTGCTGGTCTC-3' (as shown in SEQ ID NO.4);
[0056] Perform PCR amplification of Dnmt3b gene fragments, and clone and sequence the PCR amplified fragments to verify the accuracy of the sequence. The verified amplified sequence is shown in SEQ ID NO.2.
[0057] 2) Determine the sequence of the sgRNA targeting site:
[0058] The sgRNA targeting site sequence of Dnmt3b gene assisted by online tool (http: / / crispr.mit.edu / ) is as follows:
[0059] D3b-...
Embodiment 2
[0091] Expression analysis of recombinant antibody (adalimumab) in recombinant CHO cells
[0092] To further test the effect of Dnmt3b-deficient CHO cells on the stability of recombinant protein (antibody) expression, based on plasmid pWTY-02, a eukaryotic expression vector driven by CMV promoter to express adalimumab was constructed. The constructed expression vector plasmids were transfected into Dnmt3b-deficient (3b-7) and normal CHO cells (CHO-K1) respectively. The transfected cells were cultured in a medium containing G418 (800 μg / mL) for 15 days to select a stable transfected cell pool, and the recombinant CHO cells were subcultured to 30 passages every 3 days. Subsequently, the recombinant CHO cells were cultured in a 125 mL culture shake flask with 30 mL protein-free, serum-free, and chemically determined CD CHO medium (Life Technologies, the medium containing 8mM L-glutamine) for 6 days to reach the number of cells Reach 1.5×10 7 , Collect the cells every day and use th...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com